Pertuzumab in Combination with Trastuzumab and Docetaxel as Adjuvant Doublet Therapy for HER2-Positive Breast Cancer: A Systematic Review.
Saved in:
| Title: | Pertuzumab in Combination with Trastuzumab and Docetaxel as Adjuvant Doublet Therapy for HER2-Positive Breast Cancer: A Systematic Review. |
|---|---|
| Authors: | Ventura, Ignacio1,2 (AUTHOR), Salcedo, Nerea Pinilla2,3 (AUTHOR), Pérez-Bermejo, Marcelino3,4 (AUTHOR) marcelino.perez@ucv.es, Pérez-Murillo, Javier4 (AUTHOR), Tejeda-Adell, Manuel1,4 (AUTHOR), Tomás-Aguirre, Francisco2,4 (AUTHOR), Legidos-García, María Ester3,4 (AUTHOR), Murillo-Llorente, María Teresa4 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 5, p1908. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
